MetaCap

Aclarion (ACON) vs Exagen (XGN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Exagen is the larger company by market cap ($92.1 million vs $3.5 million), about 26.1 times the size, while Aclarion is growing revenue faster (+65.6% vs +19.7%). Exagen converts more of its revenue into profit, with a net margin of -30.0% versus -9551.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACON-47.98%XGN-56.51%
+8%-26%-60%
Oct 7, 20261 yearNov 20, 2026
ACON-47.76%XGN-57.13%
+5%-28%-60%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACON versus XGN key metrics
MetricACONXGN
Share price$1.22$3.61
Market cap$3.52M$92.10M
1-day change-13.92%-5.00%
YTD return—-40.63%
1-year return—-52.56%
5-year return—-67.24%
EPS (TTM)$-5.01$-0.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$75.73K$66.58M
Revenue growth (YoY)+65.62%+19.65%
Net income (latest FY)$-7.23M$-19.95M
Gross margin9.02%58.28%
Operating margin-9312.55%-21.13%
Net margin-9551.87%-29.97%
52-week high$9.36$9.22
52-week low$1.22$2.59
Distance from 52-week high-86.94%-60.85%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+524.18%+185.04%
Average volume34.73K470.43K
Shares outstanding2.88M25.51M
Employees10216
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Exagen is about 26.1 times larger than Aclarion by market value ($92.10M vs $3.52M).
  • Exagen is more profitable, keeping -30.0 cents of every revenue dollar as net income versus -9551.9 cents for Aclarion.
  • Aclarion grew revenue faster in its latest fiscal year (+65.62% vs +19.65%).

About Aclarion

ACON stock →

Aclarion, Inc. operates as a healthcare technology company in the United States.

Health Care · Medical Specialities · 10 employees

About Exagen

XGN stock →

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Health Care · Medical Specialities · 216 employees

ACON vs XGN FAQ

Which is bigger, Aclarion or Exagen?

Exagen (XGN) is larger, with a market capitalization of $92.10M compared with $3.52M for Aclarion (ACON).

Are Aclarion and Exagen in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons